Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% f

Arcutis Biotherapeutics, Inc. (ARQT)

We couldn't retrieve the full text for this release. Read it on the company's site.